Roberto Latagliata
Roberto Latagliata
Cellular Biotechnologies and Hematology
Verified email at
TitleCited byYear
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
N Engl J Med 368, 22-33, 2013
Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
U Testa, R Riccioni, S Militi, E Coccia, E Stellacci, P Samoggia, ...
Blood, The Journal of the American Society of Hematology 100 (8), 2980-2988, 2002
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients
G Visani, C Finelli, U Castelli, MC Petti, P Ricci, N Vianelli, L Gianni, ...
British journal of haematology 75 (1), 4-9, 1990
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
G Avvisati, F Lo-Coco, FP Paoloni, MC Petti, D Diverio, M Vignetti, ...
Blood, The Journal of the American Society of Hematology 117 (18), 4716-4725, 2011
Fludarabine, cytarabine, and G‐CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
M Montillo, S Mirto, MC Petti, R Latagliata, S Magrin, A Pinto, V Zagonel, ...
American journal of hematology 58 (2), 105-109, 1998
Negative prognostic value of glutathione S-transferase(GSTM1 and GSTT1) deletions in adult acute myeloid leukemia
MT Voso, F D'Alo', R Putzulu, L Mele, A Scardocci, P Chiusolo, ...
Blood, The Journal of the American Society of Hematology 100 (8), 2703-2707, 2002
CD 7 positive acute myeloid leukaemia: a subtype associated with cell immaturity
FL Coco, GD Rossi, D Pasqualetti, M Lopez, D Diverio, R Latagliata, ...
British journal of haematology 73 (4), 480-485, 1989
Therapy-related myelodysplastic syndrome–acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
R Latagliata, MC Petti, S Fenu, M Mancini, MAA Spiriti, M Breccia, ...
Blood, The Journal of the American Society of Hematology 99 (3), 822-824, 2002
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia
F Mandelli, MC Petti, A Ardia, N Di Pietro, F Di Raimondo, F Ganzina, ...
European Journal of Cancer and Clinical Oncology 27 (6), 750-755, 1991
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic …
MT Voso, S Fenu, R Latagliata, F Buccisano, A Piciocchi, MA Aloe-Spiriti, ...
Journal of clinical oncology 31 (21), 2671-2677, 2013
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
MAA Spiriti, R Latagliata, P Niscola, A Cortelezzi, M Francesconi, ...
Annals of hematology 84 (3), 167-176, 2005
Melphalan treatment in patients with myelofibrosis with myeloid metaplasia
MC Petti, R Latagliata, T Spadea, A Spadea, E Montefusco, ...
British journal of haematology 116 (3), 576-581, 2002
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary results.
MC Petti, F Mandelli, V Zagonel, CG De, MC Merola, R Latagliata, ...
Leukemia 7, 36-41, 1993
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features
M Breccia, G Avvisati, R Latagliata, I Carmosino, A Guarini, MS De Propris, ...
Leukemia 21 (1), 79-83, 2007
Identification of risk factors in atypical chronic myeloid leukemia
M Breccia, F Biondo, R Latagliata, I Carmosino, F Mandelli, G Alimena
Haematologica 91 (11), 1566-1568, 2006
Survival of elderly patients with acute myeloid leukemia
A Pulsoni, L Pagano, R Latagliata, M Casini, R Cerri, M Crugnola, ...
haematologica 89 (3), 296-302, 2004
Treatment of elderly patients (≥ 60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA …
F Mandelli, R Latagliata, G Avvisati, P Fazi, F Rodeghiero, F Leoni, ...
Leukemia 17 (6), 1085-1090, 2003
Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians
EN Oliva, F Nobile, G Alimena, F Ronco, G Specchia, S Impera, M Breccia, ...
Haematologica 96 (5), 696-702, 2011
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.
A Spadea, MC Petti, P Fazi, ML Vegna, W Arcese, G Avvisati, MAS Aloe, ...
Leukemia 7 (4), 549-552, 1993
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
A Palumbo, A Waage, C Hulin, M Beksac, S Zweegman, F Gay, P Gimsing, ...
haematologica 98 (1), 87-94, 2013
The system can't perform the operation now. Try again later.
Articles 1–20